Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 studyKevin H.M. Kuo, Elliott Vichinsky, Ashutosh Lal et al.|The Lancet|2022Cited by 87